Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

Tenosynovial Giant Cell Tumour (TGCT)

Become part of our growing rare cancer community.
Join our Facebook support group

Join Now

Posted by fatima.shakeel@opmc.co | Jun 25, 2025

What is Tenosynovial Giant Cell Tumour (TGCT)?

Tenosynovial giant cell tumour (TGCT) is a non-cancerous (benign) growth that forms near a joint or tendon sheath (the covering around tendons). It is a type of soft tissue tumour characterised by an overgrowth of the synovial lining. It usually causes swelling, pain, or stiffness in the affected joint.

There are two main types:

  1. Localised TGCT: Small, slow-growing, often in fingers or hands.
  2. Diffuse TGCT: Larger, more aggressive, usually in big joints like the knee, hip, or shoulder.

Causes

The exact cause is not known, but possible reasons include:

  • A genetic mutation that causes abnormal cell growth.
  • In some cases, repeated joint injury or irritation might play a role.
  • It is not caused by an infection and not contagious.

Risk Population

  • Usually affects young adults between 20–50 years old.
  • It can happen in men and women, but the diffuse type is more common in younger adults.

Signs & Symptoms

  • Swelling near a joint (usually painless at first).
  • Joint pain, stiffness, or trouble moving the joint.
  • A lump or bump that may grow slowly.
  • In diffuse TGCT, symptoms can be more severe and longer-lasting.

Diagnosis

It is done by following tests:

  • Physical exam to feel the lump and check joint movement.
  • MRI scan to see the size and location of the tumour.
  • X-ray to check if any bone is involved.
  • Sometimes a biopsy (small tissue sample) is taken to confirm it.

Treatment

For Localised TGCT, Surgery is usually done to remove the tumour. Most people recover well, and it rarely comes back.

For Diffuse TGCT, Surgery is more complex and may involve removing more tissue. If it grows back or is hard to remove, Radiation therapy may be used to stop it from growing. Newer medicines like targeted therapy (e.g., pexidartinib) can help shrink the tumour.

Prognosis

TGCT is not cancer, so it doesn’t spread to other body parts. Localised TGCT usually has an excellent outcome after surgery. Diffuse TGCT can be more difficult, but treatment helps manage symptoms. Regular follow-up is important to check for regrowth.


You can help us with your donation:

Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:

Donations — Without a Ribbon is grateful when we receive every donation. Giving to Without a Ribbon helps us to provide ongoing support, organise the annual gathering and subsidise the costs of our Warriors attending these conferences.
Sponsorship — If you wish to sponsor our charity, please contact us using this form.
Volunteering — We are always looking for volunteers to help with different aspects of running our charity. So, if you are looking for volunteer work, please feel free to contact us.

Share:

PreviousOur New Resource Page for Tenosynovial Giant Cell Tumour
NextWhat is Peritoneal Carcinomatosis?

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter